Collectively, these results evidence that RPTOR blockade can suppress the BM of NSCLC by attenuating the SPHK2/S1P/STAT3 pathway via hijacking the YY1 binding. The gene discussed is MBTPS1; the disease is non-small cell lung carcinoma.